Pharmacy costs now account for 25% of the Healthcare Purchaser Alliance's book of business spend, and the upward cost trend shows no sign of abating. If anything, experts expect cost increases to pick up steam in the coming years as more expensive specialty drugs like gene and cell therapies come to market. So what can employers and public purchasers do to mitigate this trend?

The answer... a lot! Join us on September 18th at The Woodlands Club in Falmouth for a discussion on pharmacy trends, strategies, and contracting with ERISA attorney Paul Holmes and industry experts from Capital Rx. We'll discuss what terms plan sponsors need to eliminate from their contracts NOW, and how innovative employers are cutting pharmacy spend by double digits through the adoption of more transparent, pass through PBM models. We’ll also cover some of the key Rx trends coming down the pike and discuss how purchasers should be preparing for a wave of high-cost drugs.

Wondering if this is the right event for you? Give this recent NYTimes article a read about the egregious practices of PBMs. You aren't going to want to miss this opportunity to become even more informed about PBMs to make decisions for your organization and bottom line.

Register now to secure your spot!

SHRM and Broker PD credits available.

Thank you, New England Cancer Specialists, for sponsoring this event!